Osaic Holdings
MBIO icon

Osaic Holdings’s Mustang Bio MBIO Stock Holding History

Osaic Holdings’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Buy
+2
New +$2 ﹤0.01% 7796
2024
Q3 		– Sell
-3
Closed -$62 – 7494
2024
Q2 		$62 Hold
3
– – ﹤0.01% 7292
2024
Q1 		$157 Sell
3
-4
-57% -$254 ﹤0.01% 6993
2023
Q4 		$487 Hold
7
– – ﹤0.01% 6895
2023
Q3 		$747 Hold
7
– – ﹤0.01% 6908
2023
Q2 		$2.24K Hold
7
– – ﹤0.01% 6625
2023
Q1 		$1.99K Hold
7
– – ﹤0.01% 6716
2022
Q4 		$2K Hold
7
– – ﹤0.01% 6673
2022
Q3 		$3K Sell
7
-27
-79% -$12.5K ﹤0.01% 6632
2022
Q2 		$15K Buy
34
+8
+31% +$4.43K ﹤0.01% 5810
2022
Q1 		$19K Buy
26
+6
+30% +$4.93K ﹤0.01% 5731
2021
Q4 		$24K Buy
20
+8
+67% +$12.9K ﹤0.01% 5674
2021
Q3 		$23K Buy
12
+2
+20% +$4.3K ﹤0.01% 5674
2021
Q2 		$26K Buy
10
+3
+43% +$7.35K ﹤0.01% 5495
2021
Q1 		$19K Buy
7
+1
+17% +$2.97K ﹤0.01% 5513
2020
Q4 		$16K Buy
6
+5
+500% +$12K ﹤0.01% 5287
2020
Q3 		$3K Buy
+1
New +$2.46K ﹤0.01% 5737
2020
Q2 		– Hold
0
– – – 6236

Other funds holding MBIO

KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CG
CFO4Life Group Coppell, Texas $656M AUM 17.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings's MBIO Position: Q1 2026 in Review

Osaic Holdings opened a new position in Mustang Bio (MBIO) in Q1 2026: 2 shares worth $1. The stake represents ﹤0.01% of the portfolio and ranks #7796 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in MBIO as recently as Q2 2024.

Osaic Holdings first reported a position in MBIO in Q3 2020 and has held it in 17 quarters since. The position peaked at $26K in Q2 2021. 22 funds tracked by Wall St. Rank hold MBIO as of Q1 2026.

  • Osaic Holdings held 2 shares of Mustang Bio worth $1 as of Q1 2026.
  • Mustang Bio was a new Osaic Holdings position in Q1 2026.
  • Mustang Bio made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7796 holding.
  • Osaic Holdings first reported a position in Mustang Bio in Q3 2020 and has held it in 17 quarters since.
  • Osaic Holdings's Mustang Bio position peaked at $26K in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.